Cargando…

Relapsing TIPIC Syndrome after Administration of an mRNA-Based COVID-19 Vaccine

Reported vascular complications following mRNA-based COVID-19 vaccines are consisting of myocarditis, cerebral venous thrombosis, cerebral vascular thrombosis, and vaccine-induced thrombocytopenia. Here, we describe a case of a 49-year-old woman with left-sided pain above the middle common carotid a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandu, Georgiana C., Weisser, Gregor, Krämer, Stefan, Reinhard, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511291/
https://www.ncbi.nlm.nih.gov/pubmed/37736104
http://dx.doi.org/10.1155/2023/6679200
_version_ 1785108105913171968
author Sandu, Georgiana C.
Weisser, Gregor
Krämer, Stefan
Reinhard, Matthias
author_facet Sandu, Georgiana C.
Weisser, Gregor
Krämer, Stefan
Reinhard, Matthias
author_sort Sandu, Georgiana C.
collection PubMed
description Reported vascular complications following mRNA-based COVID-19 vaccines are consisting of myocarditis, cerebral venous thrombosis, cerebral vascular thrombosis, and vaccine-induced thrombocytopenia. Here, we describe a case of a 49-year-old woman with left-sided pain above the middle common carotid artery (carotidynia) starting a few days after her second vaccination with an mRNA-based COVID-19 vaccine (Spikevax). Imaging was indicative of transient perivascular inflammation of the carotid artery (TIPIC) syndrome. The diagnostic workup for other immunologically mediated diseases was negative. The inflammation subsided after a course of prednisone and aspirin, and clinical symptoms vanished, but later mildly relapsed in the context of a viral upper respiratory tract infection other than SARS-CoV-2. Carotidynia because of TIPIC syndrome may present as an immunogenic side effect of the newly developed mRNA-based vaccinations against COVID-19. TIPIC syndrome should be considered in new-onset neck pain after vaccination.
format Online
Article
Text
id pubmed-10511291
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105112912023-09-21 Relapsing TIPIC Syndrome after Administration of an mRNA-Based COVID-19 Vaccine Sandu, Georgiana C. Weisser, Gregor Krämer, Stefan Reinhard, Matthias Case Rep Vasc Med Case Report Reported vascular complications following mRNA-based COVID-19 vaccines are consisting of myocarditis, cerebral venous thrombosis, cerebral vascular thrombosis, and vaccine-induced thrombocytopenia. Here, we describe a case of a 49-year-old woman with left-sided pain above the middle common carotid artery (carotidynia) starting a few days after her second vaccination with an mRNA-based COVID-19 vaccine (Spikevax). Imaging was indicative of transient perivascular inflammation of the carotid artery (TIPIC) syndrome. The diagnostic workup for other immunologically mediated diseases was negative. The inflammation subsided after a course of prednisone and aspirin, and clinical symptoms vanished, but later mildly relapsed in the context of a viral upper respiratory tract infection other than SARS-CoV-2. Carotidynia because of TIPIC syndrome may present as an immunogenic side effect of the newly developed mRNA-based vaccinations against COVID-19. TIPIC syndrome should be considered in new-onset neck pain after vaccination. Hindawi 2023-09-13 /pmc/articles/PMC10511291/ /pubmed/37736104 http://dx.doi.org/10.1155/2023/6679200 Text en Copyright © 2023 Georgiana C. Sandu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sandu, Georgiana C.
Weisser, Gregor
Krämer, Stefan
Reinhard, Matthias
Relapsing TIPIC Syndrome after Administration of an mRNA-Based COVID-19 Vaccine
title Relapsing TIPIC Syndrome after Administration of an mRNA-Based COVID-19 Vaccine
title_full Relapsing TIPIC Syndrome after Administration of an mRNA-Based COVID-19 Vaccine
title_fullStr Relapsing TIPIC Syndrome after Administration of an mRNA-Based COVID-19 Vaccine
title_full_unstemmed Relapsing TIPIC Syndrome after Administration of an mRNA-Based COVID-19 Vaccine
title_short Relapsing TIPIC Syndrome after Administration of an mRNA-Based COVID-19 Vaccine
title_sort relapsing tipic syndrome after administration of an mrna-based covid-19 vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511291/
https://www.ncbi.nlm.nih.gov/pubmed/37736104
http://dx.doi.org/10.1155/2023/6679200
work_keys_str_mv AT sandugeorgianac relapsingtipicsyndromeafteradministrationofanmrnabasedcovid19vaccine
AT weissergregor relapsingtipicsyndromeafteradministrationofanmrnabasedcovid19vaccine
AT kramerstefan relapsingtipicsyndromeafteradministrationofanmrnabasedcovid19vaccine
AT reinhardmatthias relapsingtipicsyndromeafteradministrationofanmrnabasedcovid19vaccine